VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CIA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CIACitizens, Inc.
$6.18$312M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCIAQuarterly Financials

Citizens, Inc. (CIA) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Citizens, Inc. (CIA) quarterly income statement — complete revenue, gross profit & net income history

CIA Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue58.23M72.07M62.81M65.09M55.65M63.47M61.73M62.08M57.71M66.85M59.39M58.53M55.91M67.26M56.18M53.73M55.36M69.91M61.58M63.56M
Revenue Growth %4.63%13.54%1.74%4.84%-3.57%-5.05%3.94%6.08%3.22%-0.61%5.72%8.92%1.01%-3.79%-8.78%-15.46%-0.23%7.6%2.94%8.94%
Medical Costs & Claims39.65M51.8M43.66M31.99M37.58M32.48M32.32M28.72M40.21M44.66M41.39M38.95M36.83M50.99M38.41M37.85M35.8M52.42M52.12M44.98M
Medical Cost Ratio %68.1%71.87%69.52%49.15%67.52%51.17%52.36%46.26%69.68%66.81%69.69%66.56%65.87%75.81%68.37%70.45%64.66%74.98%84.63%70.77%
Gross Profit18.57M20.27M19.15M33.1M18.08M31M29.41M33.36M17.5M22.19M18M19.57M19.08M16.27M17.77M15.88M19.56M17.49M9.46M18.58M
Gross Margin %31.9%28.13%30.48%50.85%32.48%48.83%47.64%53.74%30.32%33.19%30.31%33.44%34.13%24.19%31.63%29.55%35.34%25.02%15.37%29.23%
Gross Profit Growth %2.74%-34.6%-34.89%-0.8%3.3%39.7%63.35%70.46%-8.3%36.39%1.32%23.25%-2.44%-6.99%87.74%-14.52%96.79%60.56%-25.3%43.96%
Operating Expenses16.2M12.41M14.67M26.18M19.86M27.28M26.37M30.06M12.57M13.41M13.36M13.53M12.37M13.94M12.95M11.91M12.38M24.3M12.19M12.98M
OpEx / Revenue %27.82%17.21%23.35%40.23%35.69%42.98%42.72%48.42%21.79%20.06%22.5%23.12%22.12%20.73%23.05%22.17%22.37%34.76%19.8%20.42%
Depreciation & Amortization171K108K192K182K259K176K152K147K144K135K132K126K122K123K125K135K153K186K193K453K
Combined Ratio %95.92%89.09%92.87%89.38%103.21%94.15%95.08%94.68%91.47%86.87%92.19%89.67%87.99%96.55%91.42%92.62%87.03%109.75%104.43%91.19%
Operating Income2.37M7.86M4.48M6.91M-1.79M3.72M3.04M3.3M4.92M8.77M4.64M6.04M6.71M2.32M4.82M3.97M7.18M-6.81M-2.73M5.6M
Operating Margin %4.08%10.91%7.13%10.62%-3.21%5.85%4.92%5.32%8.53%13.13%7.81%10.33%12.01%3.45%8.58%7.38%12.97%-9.75%-4.43%8.81%
Operating Income Growth %232.85%111.63%47.48%109.39%-136.28%-57.65%-34.56%-45.37%-26.66%277.7%-3.75%52.4%-6.45%134.1%276.82%-29.18%361.21%-190.04%66.63%1178.54%
EBITDA2.54M7.97M4.67M7.1M-1.53M3.89M3.19M3.45M5.07M8.91M4.77M6.17M6.84M2.45M4.95M4.1M7.33M-6.63M-2.53M6.05M
EBITDA Margin %4.37%11.06%7.44%10.9%-2.75%6.13%5.17%5.56%8.78%13.33%8.04%10.54%12.23%3.64%8.81%7.63%13.24%-9.48%-4.11%9.52%
Interest Expense00000000000000000000
Non-Operating Income00000000000000000000
Pretax Income2.37M7.86M4.48M6.91M-1.79M3.72M3.04M3.3M4.92M8.77M4.64M6.04M6.71M2.32M4.82M3.97M7.18M-6.81M-2.73M5.6M
Pretax Margin %4.08%10.91%7.13%10.62%-3.21%5.85%4.92%5.32%8.53%13.13%7.81%10.33%12.01%3.45%8.58%7.38%12.97%-9.75%-4.43%8.81%
Income Tax106K526K2.06M455K-164K95K247K-657K383K-1.97M1.94M-82K1.84M-1.05M1.42M1.47M729K-44.95M72K578K
Effective Tax Rate %4.47%6.69%46.04%6.58%9.18%2.56%8.13%-19.9%7.78%-22.42%41.87%-1.36%27.45%-45.24%29.34%37.17%10.16%659.77%-2.64%10.32%
Net Income2.27M7.34M2.42M6.46M-1.62M3.62M2.79M3.96M4.54M10.74M2.7M6.13M4.87M3.37M3.41M2.49M6.45M38.14M-2.8M5.02M
Net Margin %3.9%10.18%3.85%9.92%-2.92%5.7%4.52%6.38%7.87%16.07%4.54%10.47%8.71%5.02%6.06%4.64%11.65%54.55%-4.55%7.9%
Net Income Growth %239.74%102.65%-13.37%63.15%-135.73%-66.29%3.41%-35.37%-6.77%218.35%-20.81%145.83%-24.45%-91.15%221.72%-50.38%280.49%2379.65%64.64%589%
EPS (Diluted)0.040.150.050.13-0.030.070.060.080.090.220.050.120.100.03-0.10-0.07-0.030.77-0.060.10
EPS Growth %236.92%106.61%-14.7%66.88%-136.19%-67%3.18%-35.08%-6.75%762.75%153.4%272.66%467.56%-96.69%-79.53%-169.5%62.52%2466.67%65.19%592.61%
EPS (Basic)0.050.150.050.13-0.030.070.060.080.090.220.050.120.100.03-0.10-0.07-0.030.77-0.060.10
Diluted Shares Outstanding50.98M50.98M50.98M50.98M50.91M49.91M50.67M50.81M50.56M49.55M50.52M50.55M50.61M49.82M50.8M51.06M50.91M49.53M50.26M50.44M